サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1775022

サル痘ワクチンと治療の世界市場

Monkeypox Vaccine and Treatment

出版日
ページ情報
英文 455 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.26円
サル痘ワクチンと治療の世界市場
出版日: 2025年07月23日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 455 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

サル痘ワクチンと治療の世界市場は2030年までに1億6,050万米ドルに達する見込み

2024年に1億40万米ドルと推定されるサル痘ワクチンと治療の世界市場は、2030年には1億6,050万米ドルに達し、分析期間2024-2030年のCAGRは8.1%で成長すると予測されます。本レポートで分析したセグメントの1つであるサル痘ワクチンは、CAGR 7.2%を記録し、分析期間終了時には1億720万米ドルに達すると予測されます。サル痘治療薬セグメントの成長率は、分析期間中CAGR 10.1%と推定されます。

米国市場は2,740万米ドルと推定、中国はCAGR 12.5％で成長すると予測

米国のサル痘ワクチンと治療市場は2024年に2,740万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024年から2030年にかけてCAGR 12.5％を辿り、2030年には予測市場規模3,420万米ドルに達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.2％と7.7％と予測されています。欧州では、ドイツがCAGR 5.4%で成長すると予測されています。

世界のサル痘ワクチンと治療市場- 主要動向と促進要因のまとめ

サル痘ワクチンと治療の需要が世界的に増加した理由とは？

世界各地でサル痘が再流行していることから、効果的なワクチンや治療に対する需要が大幅に増加しています。以前は中央アフリカと西アフリカに限定されたまれな人獣共通感染症と考えられていたサル痘は、現在では多くの国に広がっており、世界保健機関（WHO）や公衆衛生機関はサル痘を世界の健康脅威の高まりに分類しています。都市部では人から人への感染も見られるようになったため、予防接種キャンペーンや抗ウイルス治療が急務となっています。政府や保健機関は、特に免疫不全者、ヘルスケア従事者、感染者に暴露された人など、リスクの高い人々に対するワクチンの調達と配布のための資金を増額しています。また、将来発生する可能性のあるアウトブレイクに対する長期的な免疫の必要性から、有効性が向上し、予防効果がより長く持続する次世代ワクチンの研究も加速しています。

どのような科学的進歩がサル痘ワクチンや治療法の開発を形成しているのでしょうか？

サル痘のワクチンと治療薬の開発は、ウイルス学、免疫学、バイオテクノロジーの進歩に大きな影響を受けています。最も広く使用されているワクチンは改良型ワクシニアウイルスアンカラ（MVA）ベースのワクチンで、もともとは天然痘用に開発されたものですが、サル痘に対する交差防御免疫のために再利用されています。安全性プロファイルを改善し、拡張性を高めた次世代ワクチンは、より少ない副作用で長期的な免疫を提供することを目指して開発中です。これと並行して、テコビリマット（TPOXX）、ブリンシドフォビル、シドフォビルなどの抗ウイルス治療が、症状の重篤度を軽減し合併症を予防する効果的な選択肢として確認されています。モノクローナル抗体を治療レジメンに組み込むことで、重症例における免疫反応を高めることも検討されています。さらに、COVID-19ワクチン接種に革命をもたらしたmRNAワクチン技術は、新たなウイルス変異に迅速に適応できる標的サル痘ワクチンの開発に応用できる可能性があるとして研究されています。研究開発への投資が増加する中、サル痘ワクチンと治療法の将来は有望であり、予防と治療成績の向上が期待されます。

政府の政策と公衆衛生戦略は市場成長にどのような影響を与えているか？

世界各国の政府は、サル痘の蔓延を抑制するために積極的なワクチン接種戦略や治療アクセスプログラムを実施しており、ワクチンや治療薬の市場需要を牽引しています。米国食品医薬品局（FDA）や欧州医薬品庁（EMA）などの規制機関による緊急使用認可（EUA）や迅速承認により、ワクチンや抗ウイルス薬の入手が加速しています。国の予防接種プログラムでは、リスクのある人々に優先的にワクチンが配られ、備蓄されていた天然痘ワクチンの配備が進みました。公衆啓発キャンペーンや地域保健活動も、ワクチン接種や早期治療の普及に貢献しています。さらに、WHOやCEPI（Coalition for Epidemic Preparedness Innovations）などの国際保健機関による資金援助イニシアティブは、大規模な臨床試験やワクチン製造能力の拡大を支援してきました。各国政府が引き続きパンデミックへの備えを優先する中、調査への投資も増加することが予想されます。

サル痘ワクチンと治療市場の成長を促す主な要因とは？

サル痘ワクチンと治療市場の成長は、患者数の増加、ワクチン開発の進展、政府の強力な介入など、いくつかの要因によって牽引されています。パンデミックへの備えとバイオセキュリティ対策への注目の高まりは、ワクチン研究への投資拡大と抗ウイルス薬の世界的備蓄につながっています。生産施設の拡張やワクチン流通経路の改善も、市場の成長を後押ししています。さらに、mRNAベースの製剤を含む新規ワクチン技術へのシフトが、市場拡大の新たな機会を生み出しています。集団予防接種プログラムや積極的な検査戦略の採用が拡大していることも、サル痘関連の医療介入に対する需要をさらに押し上げています。さらに、製薬会社と政府間の非公開パートナーシップにより、ワクチンの迅速な普及と治療への公平なアクセスが確保されています。サル痘は公衆衛生上の脅威であり続けているため、ワクチン・治療市場は、現在進行中の研究や世界のワクチン接種イニシアチブに後押しされ、持続的な成長が見込まれます。

セグメント

製品タイプ（サル痘ワクチン、サル痘治療薬）;性別（男性、女性、その他）;投与経路（経口投与、注射投与）;エンドユーザー（病院エンドユーザー、専門クリニックエンドユーザー、その他エンドユーザー）

調査対象企業の例

  • Abbott Laboratories
  • AstraZeneca plc
  • Bavarian Nordic A/S
  • BioFactura, Inc.
  • BioNTech SE
  • Chimerix, Inc.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • KM Biologics Co., Ltd.
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • SIGA Technologies, Inc.
  • Tonix Pharmaceuticals Holding Corp.

AI統合

当社は、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP32213

Global Monkeypox Vaccine and Treatment Market to Reach US$160.5 Million by 2030

The global market for Monkeypox Vaccine and Treatment estimated at US$100.4 Million in the year 2024, is expected to reach US$160.5 Million by 2030, growing at a CAGR of 8.1% over the analysis period 2024-2030. Monkeypox Vaccines, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$107.2 Million by the end of the analysis period. Growth in the Monkeypox Drugs segment is estimated at 10.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$27.4 Million While China is Forecast to Grow at 12.5% CAGR

The Monkeypox Vaccine and Treatment market in the U.S. is estimated at US$27.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$34.2 Million by the year 2030 trailing a CAGR of 12.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Monkeypox Vaccine and Treatment Market - Key Trends & Drivers Summarized

Why Has the Demand for Monkeypox Vaccines and Treatments Increased Worldwide?

The resurgence of monkeypox in multiple regions across the globe has led to a significant rise in demand for effective vaccines and treatments. Previously considered a rare zoonotic disease confined to Central and West Africa, monkeypox has now spread to numerous countries, prompting the World Health Organization (WHO) and public health agencies to classify it as a growing global health threat. The emergence of human-to-human transmission in urban settings has intensified the urgency for immunization campaigns and antiviral treatments to curb outbreaks. Governments and health organizations have increased funding for vaccine procurement and distribution, particularly for high-risk populations such as immunocompromised individuals, healthcare workers, and those exposed to infected individuals. The need for long-term immunity against potential future outbreaks has also accelerated research into next-generation vaccines with improved efficacy and longer-lasting protection.

What Scientific Advancements Are Shaping the Development of Monkeypox Vaccines and Treatments?

The development of vaccines and therapeutics for monkeypox has been significantly influenced by advances in virology, immunology, and biotechnology. The most widely used vaccines are modified vaccinia virus Ankara (MVA)-based vaccines, originally developed for smallpox but repurposed due to their cross-protective immunity against monkeypox. Next-generation vaccines with improved safety profiles and higher scalability are under development, aiming to provide long-term immunity with fewer side effects. In parallel, antiviral treatments such as tecovirimat (TPOXX), brincidofovir, and cidofovir have been identified as effective options for reducing symptom severity and preventing complications. The integration of monoclonal antibodies into treatment regimens is also being explored to enhance immune response in severe cases. Additionally, mRNA vaccine technology, which revolutionized COVID-19 vaccination, is being studied for its potential application in developing targeted monkeypox vaccines with rapid adaptability to emerging viral mutations. With increasing investment in research and development, the future of monkeypox vaccines and treatments looks promising, offering improved protection and treatment outcomes.

How Are Government Policies and Public Health Strategies Influencing Market Growth?

Governments worldwide have implemented aggressive vaccination strategies and treatment access programs to control the spread of monkeypox, driving market demand for vaccines and therapeutics. Emergency use authorizations (EUAs) and fast-track approvals by regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accelerated the availability of vaccines and antiviral drugs. National immunization programs have prioritized at-risk populations, leading to increased vaccine distribution and deployment of stockpiled smallpox vaccines. Public awareness campaigns and community health initiatives have further contributed to vaccination uptake and early treatment adoption. Additionally, funding initiatives by global health organizations, including the WHO and the Coalition for Epidemic Preparedness Innovations (CEPI), have supported large-scale clinical trials and expanded vaccine manufacturing capabilities. As governments continue to prioritize pandemic preparedness, investment in monkeypox vaccine and treatment research is expected to rise.

What Are the Key Factors Driving the Growth of the Monkeypox Vaccine and Treatment Market?

The growth in the monkeypox vaccine and treatment market is driven by several factors, including the rising number of cases, advancements in vaccine development, and strong government intervention. The increased focus on pandemic preparedness and biosecurity measures has led to higher investments in vaccine research and global stockpiling of antiviral drugs. The expansion of production facilities and improvements in vaccine distribution channels are also fueling market growth. Additionally, the shift toward novel vaccine technologies, including mRNA-based formulations, is creating new opportunities for market expansion. The growing adoption of mass immunization programs and proactive testing strategies is further driving demand for monkeypox-related medical interventions. Furthermore, public-private partnerships between pharmaceutical companies and governments are ensuring rapid vaccine rollout and equitable access to treatments. As monkeypox continues to pose a public health threat, the market for vaccines and treatments is expected to witness sustained growth, driven by ongoing research and global vaccination initiatives.

SCOPE OF STUDY:

The report analyzes the Monkeypox Vaccine and Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Monkeypox Vaccines, Monkeypox Drugs); Gender (Male Gender, Female Gender, Other Genders); Administration Route (Oral Administration, Injectable Administration); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • Abbott Laboratories
  • AstraZeneca plc
  • Bavarian Nordic A/S
  • BioFactura, Inc.
  • BioNTech SE
  • Chimerix, Inc.
  • Emergent BioSolutions Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • KM Biologics Co., Ltd.
  • Merck & Co., Inc.
  • Moderna, Inc.
  • Novavax, Inc.
  • Pfizer Inc.
  • Roche Holding AG
  • Sanofi S.A.
  • Serum Institute of India Pvt. Ltd.
  • SIGA Technologies, Inc.
  • Tonix Pharmaceuticals Holding Corp.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Monkeypox Vaccine and Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Monkeypox Outbreaks Accelerates Global Demand for Vaccines and Therapeutics
    • Rising Global Awareness of Monkeypox as a Threat to Public Health Drives Vaccine and Treatment Adoption
    • Increasing Government and Global Health Organization Investments Strengthen Market Opportunities for Monkeypox Vaccines
    • Expansion of Vaccine Distribution Networks Enhances Global Access and Adoption of Monkeypox Vaccines
    • Advancements in Vaccine Technology Improve Efficacy and Speed of Development for Monkeypox Vaccines
    • Strong Focus on Emergency Preparedness and Pandemic Response Systems Expands Market for Monkeypox Vaccines and Treatments
    • Increasing Number of Monkeypox Cases in Non-endemic Regions Boosts Demand for Preventive and Therapeutic Solutions
    • Rising Public Health Funding and Global Collaboration on Infectious Disease Prevention Strengthens Business Case for Monkeypox Vaccines
    • Growing Demand for Monoclonal Antibodies and Antiviral Treatments for Monkeypox Drives Innovation in Therapeutics
    • Technological Advancements in Vaccine Manufacturing Processes Enable Faster Production and Scalability for Monkeypox Vaccines
    • Regulatory Approvals and Emergency Use Authorizations Accelerate Market Entry and Adoption of Monkeypox Vaccines and Treatments
    • Increasing Incidents of Monkeypox in High-Risk Populations Creates Urgency for Targeted Vaccination Programs
    • Heightened Focus on Vaccine Equity and Access in Low- and Middle-income Countries Expands Market Reach for Monkeypox Vaccines
    • Adoption of Preventive Vaccination Strategies in Endemic and Non-endemic Regions Accelerates Growth in Vaccine Demand
    • Rising Concern Over Cross-border Transmission of Monkeypox in International Travel Propels Demand for Vaccines
    • Integration of Monkeypox Vaccines into Routine Immunization Programs Strengthens Long-term Growth Outlook
    • Emergence of New Treatment Modalities and Drug Therapies for Monkeypox Expands Market Options for Healthcare Providers
    • Advancements in Vaccine Delivery Platforms, Including Intradermal and Nasal Vaccines, Enhance Market Appeal
    • Public-private Partnerships to Address Infectious Disease Control Accelerate Development and Distribution of Monkeypox Vaccines and Treatments
    • Ongoing Research into Broader Spectrum Vaccines for Orthopoxviruses Increases Market Potential for Monkeypox Immunization
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Monkeypox Vaccine and Treatment Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Monkeypox Vaccine and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Monkeypox Vaccine and Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Monkeypox Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Monkeypox Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Monkeypox Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Monkeypox Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Monkeypox Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Monkeypox Drugs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Male Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Male Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Male Gender by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Female Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Female Gender by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Female Gender by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other Genders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other Genders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other Genders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Oral Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Oral Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Injectable Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Injectable Administration by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Injectable Administration by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 35: USA Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Canada Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Canada 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • JAPAN
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Japan Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Japan 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • CHINA
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 71: China Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 74: China Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: China Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: China 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 77: China Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • EUROPE
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Monkeypox Vaccine and Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • FRANCE
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 107: France Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: France Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: France 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • GERMANY
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Germany Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: Germany 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Germany Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: Germany 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 125: Italy Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Italy Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Italy 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Italy Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Italy 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Italy Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Italy 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 134: UK Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: UK Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: UK 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 137: UK Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: UK Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: UK 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 140: UK Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: UK Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: UK 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 143: UK Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: UK Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: UK 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 146: Spain Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Spain Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Spain 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 149: Spain Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Spain Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Spain 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Spain Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Spain 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Spain Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Spain 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 158: Russia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Russia Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Russia 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 161: Russia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Russia Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Russia 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Russia Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Russia 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Russia Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Russia 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Europe Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Rest of Europe Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Rest of Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Rest of Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Rest of Europe 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 183: Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 197: Australia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Australia Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Australia 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 200: Australia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Australia Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Australia 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Australia Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Australia 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Australia Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 208: Australia 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • INDIA
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 209: India Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 210: India Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 211: India 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 212: India Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 213: India Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 214: India 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 215: India Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 216: India Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 217: India 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 218: India Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 219: India Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 220: India 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 221: South Korea Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 222: South Korea Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 223: South Korea 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 224: South Korea Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 225: South Korea Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 226: South Korea 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 228: South Korea Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 229: South Korea 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 231: South Korea Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 232: South Korea 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Rest of Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 245: Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 246: Latin America Historic Review for Monkeypox Vaccine and Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 247: Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 248: Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Latin America Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 250: Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Latin America Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 253: Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Latin America Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 256: Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Latin America Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 259: Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 260: Argentina Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Argentina Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 262: Argentina 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 263: Argentina Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Argentina Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 265: Argentina 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Argentina Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 268: Argentina 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Argentina Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 271: Argentina 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 272: Brazil Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Brazil Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 274: Brazil 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 275: Brazil Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Brazil Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 277: Brazil 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Brazil Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 280: Brazil 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Brazil Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 283: Brazil 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 284: Mexico Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Mexico Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 286: Mexico 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 287: Mexico Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Mexico Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 289: Mexico 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Mexico Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 292: Mexico 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Mexico Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 295: Mexico 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Latin America Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Latin America Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 304: Rest of Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Latin America 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 308: Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 309: Middle East Historic Review for Monkeypox Vaccine and Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 310: Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 311: Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Middle East Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 313: Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Middle East Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 316: Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Middle East Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 319: Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Middle East Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 322: Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 323: Iran Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Iran Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 325: Iran 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 326: Iran Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Iran Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 328: Iran 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 330: Iran Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 331: Iran 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Iran Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 334: Iran 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 335: Israel Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Israel Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 337: Israel 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 338: Israel Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Israel Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 340: Israel 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Israel Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 343: Israel 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Israel Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 346: Israel 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Saudi Arabia Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 349: Saudi Arabia 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Saudi Arabia Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 352: Saudi Arabia 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 355: Saudi Arabia 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 358: Saudi Arabia 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 359: UAE Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 360: UAE Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 361: UAE 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 362: UAE Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 363: UAE Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 364: UAE 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 366: UAE Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 367: UAE 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 369: UAE Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 370: UAE 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Rest of Middle East Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 373: Rest of Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Rest of Middle East Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 376: Rest of Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 379: Rest of Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 382: Rest of Middle East 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030
  • AFRICA
    • Monkeypox Vaccine and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 383: Africa Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 384: Africa Historic Review for Monkeypox Vaccine and Treatment by Product Type - Monkeypox Vaccines and Monkeypox Drugs Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 385: Africa 15-Year Perspective for Monkeypox Vaccine and Treatment by Product Type - Percentage Breakdown of Value Sales for Monkeypox Vaccines and Monkeypox Drugs for the Years 2015, 2025 & 2030
    • TABLE 386: Africa Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 387: Africa Historic Review for Monkeypox Vaccine and Treatment by End-Use - Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 388: Africa 15-Year Perspective for Monkeypox Vaccine and Treatment by End-Use - Percentage Breakdown of Value Sales for Other End-Uses, Hospitals End-Use and Specialty Clinics End-Use for the Years 2015, 2025 & 2030
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 390: Africa Historic Review for Monkeypox Vaccine and Treatment by Gender - Male Gender, Female Gender and Other Genders Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 391: Africa 15-Year Perspective for Monkeypox Vaccine and Treatment by Gender - Percentage Breakdown of Value Sales for Male Gender, Female Gender and Other Genders for the Years 2015, 2025 & 2030
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Africa Historic Review for Monkeypox Vaccine and Treatment by Administration Route - Oral Administration and Injectable Administration Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 394: Africa 15-Year Perspective for Monkeypox Vaccine and Treatment by Administration Route - Percentage Breakdown of Value Sales for Oral Administration and Injectable Administration for the Years 2015, 2025 & 2030

IV. COMPETITION